Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
BIO-PATH HOLDINGS, INC. entered into Purchase Agreement with certain institutional investors valued at approximately $1.2 million (effective 2024-04-18).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- certain institutional investors
- Value
- approximately $1.2 million
- Effective
- 2024-04-18
Exact text from the filing
On April 18, 2024, Bio-Path Holdings, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors, pursuant to which the Company agreed to sell, in a registered direct offering (the “Registered Direct Offering”), an aggregate of 375,000 shares (the “Shares”) of its common stock, par value $0.001 per share (“Common Stock”), for a purchase price per Share of $3.225 and gross proceeds of approximately $1.2 million.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
BIO-PATH HOLDINGS, INC. entered into Engagement Letter with H.C. Wainwright & Co., LLC (effective 2024-03-22).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- H.C. Wainwright & Co., LLC
- Effective
- 2024-03-22
Exact text from the filing
On March 22, 2024, the Company entered into an engagement letter (the “Engagement Letter”) with H.C. Wainwright & Co., LLC (the “Placement Agent”).
View on SEC.gov